|
|
|
Insider
Information: |
Wood Gavin |
Relationship: |
Chief Financial Officer |
City: |
Santa Clara |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
96,000 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$100,800 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
96,000 |
|
|
Total
Value |
$100,800 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-7.8%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Affymetrix Inc |
AFFX |
EVP, Chief Financial O... |
2016-03-31 |
0 |
|
0 |
Premium* |
|
Adaptimmune Therapeutics PLC |
ADAP |
Chief Financial Officer |
2022-05-20 |
96,000 |
2020-06-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2015-07-26 |
4 |
D |
$11.05 |
$1,558 |
D/D |
(141) |
98,358 |
0 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2015-08-30 |
4 |
D |
$9.48 |
$23,586 |
D/D |
(2,488) |
95,870 |
0 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2015-11-17 |
4 |
D |
$9.07 |
$5,424 |
D/D |
(598) |
96,022 |
0 |
- |
|
AFFX |
Affymetrix Inc |
EVP, Chief Financial Officer |
|
2016-02-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(671) |
95,351 |
0 |
- |
|
AFFX |
Affymetrix Inc |
EVP, Chief Financial Officer |
|
2016-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
29,859 |
125,210 |
0 |
- |
|
AFFX |
Affymetrix Inc |
EVP, Chief Financial Officer |
|
2016-02-13 |
4 |
D |
$14.09 |
$134,954 |
D/D |
(9,578) |
115,632 |
0 |
- |
|
AFFX |
Affymetrix Inc |
EVP, Chief Financial Officer |
|
2016-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
26,504 |
142,136 |
0 |
- |
|
AFFX |
Affymetrix Inc |
EVP, Chief Financial Officer |
|
2016-02-19 |
4 |
D |
$13.98 |
$70,166 |
D/D |
(5,019) |
137,117 |
0 |
- |
|
AFFX |
Affymetrix Inc |
EVP, Chief Financial Officer |
|
2016-03-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(137,573) |
0 |
0 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
Chief Financial Officer |
|
2020-06-29 |
4 |
B |
$1.62 |
$53,460 |
D/D |
33,000 |
33,000 |
2.74 |
% |
|
ADAP |
Adaptimmune Therapeutics ... |
Chief Financial Officer |
|
2020-12-14 |
4 |
B |
$0.69 |
$16,550 |
D/D |
24,000 |
57,000 |
2.74 |
% |
|
ADAP |
Adaptimmune Therapeutics ... |
Chief Financial Officer |
|
2022-05-20 |
4 |
B |
$0.29 |
$11,326 |
D/D |
39,000 |
96,000 |
2.74 |
% |
|
AFFX |
Affymetrix Inc |
Chief Financial OfficerOfficer |
|
2013-05-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,412 |
|
- |
|
38 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|